Reported Standalone quarterly numbers for Jubilant Pharmova are:
Net Sales at Rs 166.70 crore in June 2024 down 23.32% from Rs. 217.40 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 10.20 crore in June 2024 down 636.84% from Rs. 1.90 crore in June 2023.
EBITDA stands at Rs. 20.70 crore in June 2024 up 2.99% from Rs. 20.10 crore in June 2023.
Jubilant Pharmo shares closed at 752.25 on July 19, 2024 (BSE) and has given 32.04% returns over the last 6 months and 94.93% over the last 12 months.
Story continues below Advertisement
| Jubilant Pharmova | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 162.70 | 201.70 | 203.90 | | Other Operating Income | 4.00 | 4.10 | 13.50 | | Total Income From Operations | 166.70 | 205.80 | 217.40 | | EXPENDITURE | | Consumption of Raw Materials | 65.50 | 74.10 | 71.90 | | Purchase of Traded Goods | -- | -1.50 | 2.60 | | Increase/Decrease in Stocks | -5.00 | 19.30 | 31.20 | | Power & Fuel | -- | -- | -- | | Employees Cost | 48.70 | 46.50 | 47.50 | | Depreciation | 13.10 | 12.70 | 11.40 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 56.30 | 55.20 | 60.00 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -11.90 | -0.50 | -7.20 | | Other Income | 19.50 | 50.10 | 15.90 | | P/L Before Int., Excpt. Items & Tax | 7.60 | 49.60 | 8.70 | | Interest | 7.60 | 8.10 | 6.40 | | P/L Before Exceptional Items & Tax | -- | 41.50 | 2.30 | | Exceptional Items | -11.20 | -- | -- | | P/L Before Tax | -11.20 | 41.50 | 2.30 | | Tax | -1.00 | 9.00 | 0.40 | | P/L After Tax from Ordinary Activities | -10.20 | 32.50 | 1.90 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -10.20 | 32.50 | 1.90 | | Equity Share Capital | 15.90 | 15.90 | 15.90 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.64 | 2.05 | 0.12 | | Diluted EPS | -0.64 | 2.05 | 0.12 | | EPS After Extra Ordinary | | Basic EPS | -0.64 | 2.05 | 0.12 | | Diluted EPS | -0.64 | 2.05 | 0.12 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
